IDev Technologies, Inc. Announces Results From Revascularization With Supera on Real World Patients (RESTORE) Study, Demonstrating Positive Clinical Outcomes in Significantly Diseased Patients With Long Lesions
1/31/2013 8:48:58 AM
More...
|
IDev Technologies, Inc. Release: Clinical Results for the Supera&#-174 Peripheral Stent System Highlighted at Leading Global Peripheral Intervention Course
1/25/2013 8:48:45 AM
More...
|
IDev Technologies, Inc. Presents Consistent Evidence Validating the Mimetic Design of SUPERA® Stent
10/23/2012 10:04:28 AM
More...
|
IDev Technologies, Inc.'s Pivotal SUPERB Trial Demonstrates SUPERA® Stent Significantly Exceeds VIVA Criteria for One-Year Patency in Femoropopliteal Artery Disease
10/11/2012 10:23:31 AM
More...
|
IDev Technologies, Inc. Announces Positive Two-Year Clinical Outcomes From Long Term Registry of the SUPERA® Stent in Femoropopliteal Artery Disease
10/11/2012 8:09:54 AM
More...
|
IDev Technologies, Inc. Release: SUPERA® Stent Approved for Private Reimbursement in Australia
9/27/2012 12:02:23 PM
More...
|
IDev Technologies, Inc. Introduces SurePath(TM) Guidewires
6/11/2012 10:13:01 AM
More...
|
IDev Technologies, Inc. Strengthens Commercial Leadership
6/7/2012 9:55:39 AM
More...
|
IDev Technologies, Inc. Release: Journal of Endovascular Therapy Publishes Two-Year Data On SUPERA(R) Stent Used in the Superficial Femoral Artery
12/15/2011 11:30:23 AM
More...
|
IDev Technologies, Inc. Receives FDA Clearance for Its SUPERA VERITAS(R) 6 French Stent Delivery System
11/10/2011 7:31:27 AM
More...
|
|